Get started
Author

Patrick Reimann

Serological SARS‐CoV‐2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID‐19 vaccine in haematological and oncological patients
2021 · Magdalena Benda, Beatrix Mutschlechner, et al. · British Journal of Haematology · 55
PDF
Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID‐19 vaccine in haemato‐oncological patients with no antibody response
2021 · Patrick Reimann, Hanno Ulmer, et al. · British Journal of Haematology · 41
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study
2023 · Dominik A Barth, Florian Moik, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients
2022 · Axel Muendlein, Luciano Severgnini, et al. · Frontiers in Oncology · 15
PDF
Prognostic value of anti-SARS-CoV-2 antibodies: a systematic review
2024 · Sylvia Mink, Patrick Reimann, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 14
PDF
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR)
2023 · Magdalena A. Benda, Hanno Ulmer, et al. · Cancers · 11
PDF
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
2022 · Verena Schlintl, Florian Huemer, et al. · BMC Cancer · 11
PDF
Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort
2026 · Oliver Illini, Anna-Carina Hund, et al. · Journal of Thoracic Oncology · 9
PDF
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
2024 · Patrick Reimann, Ilektra-Antonia Mavroeidi, et al. · Cancer Immunology Immunotherapy · 9
PDF
Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study
2024 · Sylvia Mink, Heinz Drexel, et al. · International Journal of Infectious Diseases · 6
PDF
Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients
2023 · Axel Muendlein, Kathrin Geiger, et al. · Journal of Cancer Research and Clinical Oncology · 6
PDF
Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics
2026 · Rafael Grochot, Michela Bartolini, et al. · American Society of Clinical Oncology Educational Book · 5
Antibody levels versus vaccination status in the outcome of older adults with COVID-19
2024 · Sylvia Mink, Christoph H. Saely, et al. · JCI Insight · 5
PDF
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review
2026 · Magdalena Benda, Patrick Reimann, et al. · Annals of Hematology · 4
Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies
2024 · Patrick Reimann, Verena Petzer, et al. · Annals of Hematology · 4
Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q
2025 · Magdalena Benda, Patrick Reimann, et al. · Cancers · 3
PDF
Interplay of kidney function and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study
2025 · Sylvia Mink, Heinz Drexel, et al. · Scientific Reports · 2
PDF
Anti‐SARS‐CoV‐2 Antibodies in Long‐COVID—Markers of Protection or Elevated Risk? A Systematic Review
2025 · Sylvia Mink, Fabian Wilhelm, et al. · Reviews in Medical Virology · 2
Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study
2024 · Michael Mark, Alfonso Rojas Mora, et al. · Bone Reports · 2
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study
2024 · Maximilian Hochmair, Angelika Terbuch, et al. · Cancers · 2
CSF-interleukin 6 for early diagnosis of ventriculitis in a broad intensive care setting
2022 · Sylvia Mink, Wolfgang List, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2
Selpercatinib in Treatment of Advanced Medullary Thyroid Cancer: Effectiveness and Side Effects – A Case Report of 2 Patients during 60 Months of Therapy
2026 · Luciano Severgnini, Bernd Hartmann, et al. · Case Reports in Oncology · 1
PDF
Interplay of statin treatment and anti-SARS-CoV-2 antibody levels in the outcome of COVID-19: a prospective, propensity score matched cohort study
2025 · Sylvia Mink, Heinz Drexel, et al. · Atherosclerosis · 1
Essential news from ASCO 2023 in primary resectable and advanced or metastatic pancreatic cancer
2023 · Patrick Reimann, Thomas Winder · memo - Magazine of European Medical Oncology · 1
Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status: The SAKK 80/19 SMOKER study.
2023 · Tämer El Saadany, Ulf Petrausch, et al. · Journal of Clinical Oncology · 1
PDF
Works count: 48
Citation count: 234
H-index: 9
I10-index: 7
Year
Topic
Type